Eye On A.I. #279 Matthew Carroll: Immuta's Approach to Secure, Scalable Data Access in the Age of AI
Aug 14, 2025
Matthew Carroll, CEO and co-founder of Immuta, dives into the transformative role of data access governance in the age of AI. He discusses how traditional security models falter against modern data demands and how Immuta automates compliance for enterprises. Matthew highlights the importance of AI-powered governance agents and risk-based access controls to safeguard sensitive data. He also explores the challenges of global data governance and the innovative technology solutions that ensure secure and efficient data management for organizations, especially in the pharmaceutical sector.
AI Snips
Chapters
Transcript
Episode notes
Blinded Clinical Trials Example
- In pharma, Immuta blinds patient, provider, and researcher to preserve FDA-compliant clinical trials worth billions.
- The platform pulls identity and data metadata and applies dynamic masking, filtering, and de-identification.
Expose Missing Access And Mediate
- Surface visibility so consumers can see what they lack and start a negotiation with governance and legal.
- Replace ticketing with policy-exception workflows that mediate access decisions interactively.
Native Integration Is Non‑Negotiable
- Native integration into compute (Snowflake, Databricks, S3) is essential for low-latency, high-volume access control.
- Proxy or virtualization approaches break at AI-scale transactional loads and must be avoided.